| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.52 | 1e-55 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.31 | 2e-27 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.32 | 1e-25 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.33 | 7e-22 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.42 | 1e-19 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-18 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.27 | 8e-17 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-16 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.4 | 1e-15 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-11 |